Ann N Y Acad Sci 2017 Nov;1407(1):63-74
School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
Iron sucrose (IS) is a complex nanocolloidal intravenous suspension used in the treatment of iron-deficiency anemia. Follow-on IS products (iron sucrose similars (ISSs)) have obtained marketing authorization by the generic pathway, implying that identical copies of IS may be manufactured. However, recent prospective and retrospective clinical studies showed discrepancies in clinical outcomes, which might be related to differences in physicochemical properties. Read More